An animal component-free bioprocess for synthesizing 3D human matrix scaffolds using mesenchymal stromal cells.
Stein SN., Braid LR.
Animal Study, published in Front Cell Dev Biol (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Front Cell Dev Biol (2026)
- Country
- Switzerland
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 42052567
- DOI
- 10.3389/fcell.2026.1624745
Abstract (original English)
The basement membrane is a specialized extracellular matrix that compartmentalizes epithelial and endothelial tissues and provides essential structural and signaling cues for tissue organization. Whereas fibrillar collagens (Col) of the interstitial matrix (such as Col I and Col III) are widely used in tissue modeling, the networking collagens that scaffold the basement membrane, including human Col IV and Col VI, remain difficult to access. Commercial basement membrane surrogates such as Matrigel® are derived from murine tumors and are ill defined, dilute, variable, and incompatible with animal-free biomanufacturing. Thus, there is a crucial need for human-derived basement membrane matrices that are free of xenogenic contaminants and do not rely on breeding animals. Here, we analyzed whether human mesenchymal stromal cells (MSCs) could serve as a platform to produce self-assembling basement membrane components under chemically defined, xeno-free conditions. MSCs from placental, umbilical cord, bone marrow, and adipose tissues were cultured as three-dimensional spheroids and adherent multilayered sheets. Confocal imaging of whole-mount, decellularized spheroid matrices showed complex networks of fibronectin (FN) and Col IV with topological and organizational features characteristic of basement membrane. Perinatal MSCs produced distinct matrix architectures consisting of apical
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.